Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41.1M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
4.68M
-
Shares change
-
+487K
-
Total reported value, excl. options
-
$24.3M
-
Value change
-
+$2.19M
-
Number of buys
-
3
-
Number of sells
-
-2
-
Price
-
$5.20
Significant Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q2 2022
9 filings reported holding ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock as of Q2 2022.
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.68M shares
of 41.1M outstanding shares and own 11.39% of the company stock.
Largest 9 shareholders include 22NW, LP (3.36M shares), LVW Advisors, LLC (700K shares), MANGROVE PARTNERS (399K shares), Ikarian Capital, LLC (181K shares), BOOTHBAY FUND MANAGEMENT, LLC (17.3K shares), BlackRock Inc. (7.33K shares), Tower Research Capital LLC (TRC) (7.14K shares), UBS Group AG (2.91K shares), and Laurion Capital Management LP (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.